annual net income:
-$157.86M-$16.43M(-11.62%)Summary
- As of today (July 2, 2025), CLDX annual net profit is -$157.86 million, with the most recent change of -$16.43 million (-11.62%) on December 31, 2024.
- During the last 3 years, CLDX annual net income has fallen by -$87.35 million (-123.88%).
- CLDX annual net income is now -19632.88% below its all-time high of -$800.00 thousand, reached on April 30, 1987.
Performance
CLDX Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
-$53.80M-$6.70M(-14.24%)Summary
- As of today (July 2, 2025), CLDX quarterly net profit is -$53.80 million, with the most recent change of -$6.70 million (-14.24%) on March 31, 2025.
- Over the past year, CLDX quarterly net income has dropped by -$20.99 million (-63.97%).
- CLDX quarterly net income is now -337.39% below its all-time high of $22.66 million, reached on December 31, 2010.
Performance
CLDX quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$178.85M-$20.99M(-13.30%)Summary
- As of today (July 2, 2025), CLDX TTM net profit is -$178.85 million, with the most recent change of -$20.99 million (-13.30%) on March 31, 2025.
- Over the past year, CLDX TTM net income has dropped by -$33.98 million (-23.45%).
- CLDX TTM net income is now -59517.00% below its all-time high of -$300.00 thousand, reached on July 1, 1985.
Performance
CLDX TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
CLDX Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.6% | -64.0% | -23.4% |
| 3 y3 years | -123.9% | -133.4% | -132.2% |
| 5 y5 years | -210.3% | -326.1% | -292.9% |
CLDX Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -123.9% | at low | -103.1% | at low | -79.5% | at low |
| 5 y | 5-year | -210.3% | at low | -387.7% | at low | -292.9% | at low |
| alltime | all time | <-9999.0% | at low | -337.4% | +54.5% | <-9999.0% | at low |
CLDX Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$53.80M(+14.2%) | -$178.85M(+13.3%) |
| Dec 2024 | -$157.86M(+11.6%) | -$47.09M(+11.8%) | -$157.86M(+2.5%) |
| Sep 2024 | - | -$42.12M(+17.5%) | -$154.08M(+2.6%) |
| Jun 2024 | - | -$35.84M(+9.2%) | -$150.22M(+3.7%) |
| Mar 2024 | - | -$32.81M(-24.2%) | -$144.88M(+2.4%) |
| Dec 2023 | -$141.43M(+25.9%) | -$43.31M(+13.2%) | -$141.43M(+13.5%) |
| Sep 2023 | - | -$38.26M(+25.4%) | -$124.61M(+10.1%) |
| Jun 2023 | - | -$30.50M(+3.9%) | -$113.13M(-4.6%) |
| Mar 2023 | - | -$29.36M(+10.9%) | -$118.64M(+5.6%) |
| Dec 2022 | -$112.33M(+59.3%) | -$26.49M(-1.1%) | -$112.33M(+6.0%) |
| Sep 2022 | - | -$26.78M(-25.6%) | -$105.99M(+6.4%) |
| Jun 2022 | - | -$36.00M(+56.2%) | -$99.65M(+29.4%) |
| Mar 2022 | - | -$23.05M(+14.4%) | -$77.02M(+9.2%) |
| Dec 2021 | -$70.51M(+18.0%) | -$20.15M(-1.5%) | -$70.51M(-2.4%) |
| Sep 2021 | - | -$20.45M(+52.9%) | -$72.26M(+9.4%) |
| Jun 2021 | - | -$13.37M(-19.1%) | -$66.03M(+3.7%) |
| Mar 2021 | - | -$16.54M(-24.5%) | -$63.69M(+6.5%) |
| Dec 2020 | -$59.78M(+17.5%) | -$21.90M(+54.0%) | -$59.78M(+23.7%) |
| Sep 2020 | - | -$14.22M(+28.9%) | -$48.33M(+6.2%) |
| Jun 2020 | - | -$11.03M(-12.6%) | -$45.52M(-1.6%) |
| Mar 2020 | - | -$12.63M(+20.8%) | -$46.26M(-9.1%) |
| Dec 2019 | -$50.88M(-66.3%) | -$10.45M(-8.5%) | -$50.88M(+2.1%) |
| Sep 2019 | - | -$11.41M(-3.1%) | -$49.83M(+9.1%) |
| Jun 2019 | - | -$11.78M(-31.7%) | -$45.66M(-9.2%) |
| Mar 2019 | - | -$17.24M(+83.3%) | -$50.29M(-66.7%) |
| Dec 2018 | -$151.18M(+62.5%) | -$9.40M(+29.8%) | -$151.19M(+3.8%) |
| Sep 2018 | - | -$7.24M(-55.9%) | -$145.62M(-11.6%) |
| Jun 2018 | - | -$16.41M(-86.1%) | -$164.74M(-6.9%) |
| Mar 2018 | - | -$118.13M(+2975.6%) | -$176.90M(+90.2%) |
| Dec 2017 | -$93.03M(-27.6%) | -$3.84M(-85.4%) | -$93.03M(-23.4%) |
| Sep 2017 | - | -$26.36M(-7.7%) | -$121.50M(-2.6%) |
| Jun 2017 | - | -$28.57M(-16.6%) | -$124.73M(-2.6%) |
| Mar 2017 | - | -$34.26M(+6.0%) | -$128.12M(-0.3%) |
| Dec 2016 | -$128.53M(+1.0%) | -$32.31M(+9.2%) | -$128.53M(-0.3%) |
| Sep 2016 | - | -$29.60M(-7.4%) | -$128.91M(-1.8%) |
| Jun 2016 | - | -$31.95M(-7.8%) | -$131.29M(-0.3%) |
| Mar 2016 | - | -$34.67M(+6.1%) | -$131.70M(+3.5%) |
| Dec 2015 | -$127.20M(+7.7%) | -$32.68M(+2.2%) | -$127.20M(+0.7%) |
| Sep 2015 | - | -$31.98M(-1.2%) | -$126.33M(+3.2%) |
| Jun 2015 | - | -$32.36M(+7.2%) | -$122.44M(+3.5%) |
| Mar 2015 | - | -$30.17M(-5.2%) | -$118.35M(+0.2%) |
| Dec 2014 | -$118.08M(+44.8%) | -$31.82M(+13.3%) | -$118.08M(+9.0%) |
| Sep 2014 | - | -$28.08M(-0.7%) | -$108.32M(+4.8%) |
| Jun 2014 | - | -$28.27M(-5.4%) | -$103.38M(+9.8%) |
| Mar 2014 | - | -$29.90M(+35.5%) | -$94.12M(+15.4%) |
| Dec 2013 | -$81.55M(+37.9%) | -$22.06M(-4.7%) | -$81.55M(+6.9%) |
| Sep 2013 | - | -$23.14M(+21.7%) | -$76.30M(+11.9%) |
| Jun 2013 | - | -$19.02M(+9.7%) | -$68.18M(+8.3%) |
| Mar 2013 | - | -$17.33M(+3.1%) | -$62.94M(+6.5%) |
| Dec 2012 | -$59.12M(+32.0%) | -$16.81M(+11.8%) | -$59.12M(+7.4%) |
| Sep 2012 | - | -$15.03M(+9.1%) | -$55.05M(+6.3%) |
| Jun 2012 | - | -$13.77M(+1.9%) | -$51.79M(+7.3%) |
| Mar 2012 | - | -$13.52M(+6.2%) | -$48.26M(+7.7%) |
| Dec 2011 | -$44.80M(+1668.6%) | -$12.73M(+8.2%) | -$44.80M(+376.3%) |
| Sep 2011 | - | -$11.77M(+15.0%) | -$9.41M(+39.9%) |
| Jun 2011 | - | -$10.24M(+1.8%) | -$6.72M(+11.8%) |
| Mar 2011 | - | -$10.06M(-144.4%) | -$6.01M(+137.3%) |
| Dec 2010 | -$2.53M(-93.1%) | $22.66M(-349.4%) | -$2.53M(-93.4%) |
| Sep 2010 | - | -$9.09M(-4.6%) | -$38.14M(+5.3%) |
| Jun 2010 | - | -$9.53M(+44.7%) | -$36.22M(+2.3%) |
| Mar 2010 | - | -$6.58M(-49.1%) | -$35.40M(-3.1%) |
| Dec 2009 | -$36.52M(-23.1%) | -$12.94M(+80.4%) | -$36.52M(+17.7%) |
| Sep 2009 | - | -$7.17M(-17.6%) | -$31.04M(-1.5%) |
| Jun 2009 | - | -$8.71M(+13.0%) | -$31.52M(-4.7%) |
| Mar 2009 | - | -$7.70M(+3.3%) | -$33.07M(-30.4%) |
| Dec 2008 | -$47.50M(+215.1%) | -$7.45M(-2.6%) | -$47.50M(+7.3%) |
| Sep 2008 | - | -$7.66M(-25.4%) | -$44.28M(+8.8%) |
| Jun 2008 | - | -$10.26M(-53.6%) | -$40.68M(+22.6%) |
| Mar 2008 | - | -$22.13M(+423.4%) | -$33.17M(+120.1%) |
| Dec 2007 | -$15.07M(-15.5%) | -$4.23M(+4.2%) | -$15.07M(+3.8%) |
| Sep 2007 | - | -$4.06M(+47.3%) | -$14.52M(-9.2%) |
| Jun 2007 | - | -$2.76M(-31.7%) | -$15.98M(-15.4%) |
| Mar 2007 | - | -$4.03M(+9.8%) | -$18.90M(+6.0%) |
| Dec 2006 | -$17.84M(-1.4%) | -$3.67M(-33.5%) | -$17.84M(-1.7%) |
| Sep 2006 | - | -$5.52M(-2.6%) | -$18.14M(+5.9%) |
| Jun 2006 | - | -$5.67M(+90.9%) | -$17.14M(+5.8%) |
| Mar 2006 | - | -$2.97M(-25.3%) | -$16.20M(-10.5%) |
| Dec 2005 | -$18.10M | -$3.98M(-11.8%) | -$18.10M(+1.6%) |
| Sep 2005 | - | -$4.51M(-4.6%) | -$17.82M(+4.8%) |
| Jun 2005 | - | -$4.73M(-2.8%) | -$17.00M(+5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2005 | - | -$4.87M(+31.6%) | -$16.16M(+22.4%) |
| Dec 2004 | -$13.20M(+4.2%) | -$3.70M(+0.0%) | -$13.20M(-2.3%) |
| Sep 2004 | - | -$3.70M(-5.2%) | -$13.51M(+13.3%) |
| Jun 2004 | - | -$3.90M(+104.2%) | -$11.93M(+6.4%) |
| Mar 2004 | - | -$1.91M(-52.4%) | -$11.22M(-11.5%) |
| Dec 2003 | -$12.67M(-8.4%) | -$4.01M(+89.5%) | -$12.67M(+4.4%) |
| Sep 2003 | - | -$2.12M(-33.5%) | -$12.14M(+17.9%) |
| Jun 2003 | - | -$3.18M(-5.3%) | -$10.30M(-16.1%) |
| Mar 2003 | - | -$3.36M(-3.2%) | -$12.28M(-11.2%) |
| Dec 2002 | -$13.83M(-39.2%) | -$3.48M(+1158.2%) | -$13.83M(-19.6%) |
| Sep 2002 | - | -$276.20K(-94.7%) | -$17.21M(-25.7%) |
| Jun 2002 | - | -$5.16M(+5.1%) | -$23.16M(-2.1%) |
| Mar 2002 | - | -$4.91M(-28.3%) | -$23.65M(+4.0%) |
| Dec 2001 | -$22.75M(+3.5%) | -$6.86M(+10.1%) | -$22.74M(-22.6%) |
| Sep 2001 | - | -$6.22M(+10.0%) | -$29.38M(+9.7%) |
| Jun 2001 | - | -$5.66M(+41.4%) | -$26.79M(+12.3%) |
| Mar 2001 | - | -$4.00M(-70.3%) | -$23.86M(+8.6%) |
| Dec 2000 | -$21.98M(+94.3%) | -$13.49M(+271.4%) | -$21.98M(+81.8%) |
| Sep 2000 | - | -$3.63M(+33.4%) | -$12.09M(+9.3%) |
| Jun 2000 | - | -$2.72M(+28.3%) | -$11.06M(+3.0%) |
| Mar 2000 | - | -$2.12M(-41.2%) | -$10.73M(-5.1%) |
| Dec 1999 | -$11.31M(-78.2%) | -$3.61M(+38.8%) | -$11.31M(+13.1%) |
| Sep 1999 | - | -$2.60M(+8.3%) | -$10.00M(-81.5%) |
| Jun 1999 | - | -$2.40M(-11.1%) | -$54.20M(+2.1%) |
| Mar 1999 | - | -$2.70M(+17.4%) | -$53.10M(+2.5%) |
| Dec 1998 | -$51.80M(+295.4%) | -$2.30M(-95.1%) | -$51.80M(+1.6%) |
| Sep 1998 | - | -$46.80M(+3500.0%) | -$51.00M(+318.0%) |
| Jun 1998 | - | -$1.30M(-7.1%) | -$12.20M(-3.2%) |
| Mar 1998 | - | -$1.40M(-6.7%) | -$12.60M(-3.8%) |
| Dec 1997 | -$13.10M(+21.3%) | -$1.50M(-81.3%) | -$13.10M(-6.4%) |
| Sep 1997 | - | -$8.00M(+370.6%) | -$14.00M(+68.7%) |
| Jun 1997 | - | -$1.70M(-10.5%) | -$8.30M(-23.9%) |
| Mar 1997 | - | -$1.90M(-20.8%) | -$10.90M(0.0%) |
| Dec 1996 | -$10.80M(+30.1%) | -$2.40M(+4.3%) | -$10.90M(+25.3%) |
| Sep 1996 | - | -$2.30M(-46.5%) | -$8.70M(-8.4%) |
| Jun 1996 | - | -$4.30M(+126.3%) | -$9.50M(+21.8%) |
| Mar 1996 | - | -$1.90M(+850.0%) | -$7.80M(-6.0%) |
| Dec 1995 | -$8.30M(-28.4%) | -$200.00K(-93.5%) | -$8.30M(-33.6%) |
| Sep 1995 | - | -$3.10M(+19.2%) | -$12.50M(+0.8%) |
| Jun 1995 | - | -$2.60M(+8.3%) | -$12.40M(+2.5%) |
| Mar 1995 | - | -$2.40M(-45.5%) | -$12.10M(+4.3%) |
| Dec 1994 | -$11.60M(+48.7%) | -$4.40M(+46.7%) | -$11.60M(+23.4%) |
| Sep 1994 | - | -$3.00M(+30.4%) | -$9.40M(+6.8%) |
| Jun 1994 | - | -$2.30M(+21.1%) | -$8.80M(+10.0%) |
| Mar 1994 | - | -$1.90M(-13.6%) | -$8.00M(+2.6%) |
| Dec 1993 | -$7.80M(+116.7%) | -$2.20M(-8.3%) | -$7.80M(+39.3%) |
| Sep 1993 | - | -$2.40M(+60.0%) | -$5.60M(+30.2%) |
| Jun 1993 | - | -$1.50M(-11.8%) | -$4.30M(+7.5%) |
| Mar 1993 | - | -$1.70M(+54.5%) | -$4.00M(-2.4%) |
| Dec 1992 | -$3.60M(-21.7%) | - | - |
| Oct 1992 | - | -$1.10M(-8.3%) | -$4.10M(-8.9%) |
| Jul 1992 | - | -$1.20M(-14.3%) | -$4.50M(-2.2%) |
| Apr 1992 | - | -$1.40M(+250.0%) | -$4.60M(+12.2%) |
| Apr 1992 | -$4.60M(+35.3%) | - | - |
| Jan 1992 | - | -$400.00K(-73.3%) | -$4.10M(-8.9%) |
| Oct 1991 | - | -$1.50M(+15.4%) | -$4.50M(+21.6%) |
| Jul 1991 | - | -$1.30M(+44.4%) | -$3.70M(+8.8%) |
| Apr 1991 | -$3.40M(+240.0%) | -$900.00K(+12.5%) | -$3.40M(+54.5%) |
| Jan 1991 | - | -$800.00K(+14.3%) | -$2.20M(+57.1%) |
| Oct 1990 | - | -$700.00K(-30.0%) | -$1.40M(0.0%) |
| Jul 1990 | - | -$1.00M(-433.3%) | -$1.40M(+40.0%) |
| Apr 1990 | -$1.00M(-9.1%) | $300.00K(-142.9%) | -$1.00M(-41.2%) |
| Oct 1989 | - | -$700.00K(+16.7%) | -$1.70M(+21.4%) |
| Jul 1989 | - | -$600.00K(-700.0%) | -$1.40M(+27.3%) |
| Apr 1989 | -$1.10M(-8.3%) | $100.00K(-120.0%) | -$1.10M(-26.7%) |
| Jan 1989 | - | -$500.00K(+25.0%) | -$1.50M(+15.4%) |
| Oct 1988 | - | -$400.00K(+33.3%) | -$1.30M(+18.2%) |
| Jul 1988 | - | -$300.00K(0.0%) | -$1.10M(-8.3%) |
| Apr 1988 | -$1.20M(+50.0%) | -$300.00K(0.0%) | -$1.20M(0.0%) |
| Jan 1988 | - | -$300.00K(+50.0%) | -$1.20M(+20.0%) |
| Oct 1987 | - | -$200.00K(-50.0%) | -$1.00M(+11.1%) |
| Jul 1987 | - | -$400.00K(+33.3%) | -$900.00K(+12.5%) |
| Apr 1987 | -$800.00K(-52.9%) | -$300.00K(+200.0%) | -$800.00K(-76.5%) |
| Jan 1987 | - | -$100.00K(0.0%) | -$3.40M(-12.8%) |
| Oct 1986 | - | -$100.00K(-66.7%) | -$3.90M(-7.1%) |
| Jul 1986 | - | -$300.00K(-89.7%) | -$4.20M(0.0%) |
| Apr 1986 | -$1.70M | -$2.90M(+383.3%) | -$4.20M(+223.1%) |
| Jan 1986 | - | -$600.00K(+50.0%) | -$1.30M(+85.7%) |
| Oct 1985 | - | -$400.00K(+33.3%) | -$700.00K(+133.3%) |
| Jul 1985 | - | -$300.00K | -$300.00K |
FAQ
- What is Celldex Therapeutics annual net profit?
- What is the all time high annual net income for Celldex Therapeutics?
- What is Celldex Therapeutics annual net income year-on-year change?
- What is Celldex Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly net income year-on-year change?
- What is Celldex Therapeutics TTM net profit?
- What is the all time high TTM net income for Celldex Therapeutics?
- What is Celldex Therapeutics TTM net income year-on-year change?
What is Celldex Therapeutics annual net profit?
The current annual net income of CLDX is -$157.86M
What is the all time high annual net income for Celldex Therapeutics?
Celldex Therapeutics all-time high annual net profit is -$800.00K
What is Celldex Therapeutics annual net income year-on-year change?
Over the past year, CLDX annual net profit has changed by -$16.43M (-11.62%)
What is Celldex Therapeutics quarterly net profit?
The current quarterly net income of CLDX is -$53.80M
What is the all time high quarterly net income for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly net profit is $22.66M
What is Celldex Therapeutics quarterly net income year-on-year change?
Over the past year, CLDX quarterly net profit has changed by -$20.99M (-63.97%)
What is Celldex Therapeutics TTM net profit?
The current TTM net income of CLDX is -$178.85M
What is the all time high TTM net income for Celldex Therapeutics?
Celldex Therapeutics all-time high TTM net profit is -$300.00K
What is Celldex Therapeutics TTM net income year-on-year change?
Over the past year, CLDX TTM net profit has changed by -$33.98M (-23.45%)